Patents by Inventor Laurent VERNILLET

Laurent VERNILLET has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF [(1R)-1-(2-CHLOROPHENYL)-2-(TETRAZOL-2-YL)ETHYL] CARBAMATE IN COMBINATION THERAPY
    Publication number: 20230293489
    Abstract: The present disclosure provides combination therapy using [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate (cenobamate) and one or more antiepileptic drugs for the prevention or treatment of a neurological disorder such as epilepsy.
    Type: Application
    Filed: April 13, 2023
    Publication date: September 21, 2023
    Inventors: Marc KAMIN, Laurent VERNILLET
  • Use of [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate in combination therapy
    Patent number: 11654133
    Abstract: The present disclosure provides combination therapy using [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate (cenobamate) and one or more antiepileptic drugs for the prevention or treatment of a neurological disorder such as epilepsy.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: May 23, 2023
    Assignee: SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Marc Kamin, Laurent Vernillet
  • Use Of [(1R)-1-(2-Chlorophenyl)-2-(Tetrazol-2-YL)Ethyl] Carbamate In Combination Therapy
    Publication number: 20210008033
    Abstract: The present disclosure provides combination therapy using [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate (cenobamate) and one or more antiepileptic drugs for the prevention or treatment of a neurological disorder such as epilepsy.
    Type: Application
    Filed: September 30, 2020
    Publication date: January 14, 2021
    Inventors: Marc KAMIN, Laurent VERNILLET
  • Use Of [(1R)-1-(2-Chlorophenyl)-2-(Tetrazol-2-YL)Ethyl] Carbamate In Combination Therapy
    Publication number: 20190365709
    Abstract: The present disclosure provides combination therapy using [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate (cenobamate) and one or more antiepileptic drugs for the prevention or treatment of a neurological disorder such as epilepsy.
    Type: Application
    Filed: March 21, 2019
    Publication date: December 5, 2019
    Applicants: SK BIOPHARMACEUTICALS CO., LTD., SK BIOPHARMACEUTICALS CO., LTD.
    Inventors: Marc KAMIN, Laurent VERNILLET